Xeris Pharmaceuticals
XERS
#4025
Rank
โ‚ฌ2.76 B
Marketcap
15,15ย โ‚ฌ
Share price
-2.18%
Change (1 day)
146.53%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2026 (TTM): โ‚ฌ8.95 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.33 Billion. In 2025 the company made an earning of โ‚ฌ27 Million, an increase over its 2024 earnings that were of -โ‚ฌ24.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ8.95 M-66.83%
2025 โ‚ฌ27 M-211.34%
2024 -โ‚ฌ24.26 Million-27.85%
2023 -โ‚ฌ33.63 Million-54.31%
2022 -โ‚ฌ73.6 Million-30.11%
2021 -โ‚ฌ0.11 Billion43.37%
2020 -โ‚ฌ73.45 Million-32.21%
2019 -โ‚ฌ0.11 Billion106.61%
2018 -โ‚ฌ52.44 Million116.69%
2017 -โ‚ฌ24.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.15 Billion-1,508.29%๐Ÿ‡บ๐Ÿ‡ธ USA